FierceBiotech 2026-02-06 UniQure pauses Fabry gene therapy dosing in 2 groups after toxicities emerge
FierceBiotech 2026-02-06 Pfizer-backed Priovant scores again with fast-rising brepocitinib in midstage study
FierceBiotech 2026-02-06 Qiagen 'open for discussion' on shareholder value, but CEO stays mum on takeover talk
FierceBiotech 2026-02-05 Racing BMS and J&J, Bayer links asundexian to 26% stroke reduction to unblock path to FDA
FierceBiotech 2026-02-05 GE HealthCare posts higher full-year revenues amid turbulent tariff backdrop
FierceBiotech 2026-02-05 Quell halts liver transplant Treg trial to focus on preclinical 'chill not kill' candidate
FierceBiotech 2026-02-05 FDA’s rare pediatric disease voucher program revived by 2026 government funding bill
FierceBiotech 2026-02-04 Lilly drops 3 pipeline drugs, including gene therapy, from $1B Prevail buyout